Abstract
Usurpation of the host’s signalling pathways is a common strategy employed by viruses to promote their successful replication. Here we show that infection with the orthopoxvirus vaccinia virus (VACV) leads to sustained stimulation of c-Jun activity during the entire infective cycle. This stimulation is temporally regulated through MEK/ERK or MKK/JNK pathways, i.e. during the early/mid phase (1 to 6 hpi) and in the late phase (9 to 24 hpi) of the infective cycle, respectively. As a transcriptional regulator, upon infection with VACV, c-Jun is translocated from the cytoplasm to the nucleus, where it binds to the AP-1 DNA sequence found at the promoter region of its target genes. To investigate the role played by c-Jun during VACV replication cycle, we generated cell lines that stably express a c-Jun-dominant negative (DNc-Jun) mutation. Our data revealed that c-Jun is required during early infection to assist with viral DNA replication, as demonstrated by the decreased amount of viral DNA found in the DNc-Jun cells. We also demonstrated that c-Jun regulates the expression of the early growth response gene (egr-1), a gene previously shown to affect VACV replication mediated by MEK/ERK signalling. VACV-induced stimulation of the MKK/JNK/JUN pathway impacts viral dissemination, as we observed a significant reduction in both viral yield, during late stages of infection, and virus plaque size. Collectively, our data suggest that, by modulating the host’s signalling pathways through a common target such as c-Jun, VACV temporally regulates its infective cycle in order to successfully replicate and subsequently spread.
Similar content being viewed by others
References
Moss B (2007) Poxviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, New York, pp 2905–2945
Smith GL et al (2013) Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 94(Pt 11):2367–2392
Brady G, Bowie AG (2014) Innate immune activation of NFkappaB and its antagonism by poxviruses. Cytokine Growth Factor Rev 25(5):611–620
Bonjardim CA, Ferreira PC, Kroon EG (2009) Interferons: signaling, antiviral and viral evasion. Immunol Lett 122(1):1–11
McFadden G (2005) Poxvirus tropism. Nat Rev Microbiol 3(3):201–213
Caceres A et al (2013) Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection. PLoS Pathog 9(11):e1003719
Andrade AA et al (2004) The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem J 381(Pt 2):437–446
de Magalhaes JC et al (2001) A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J Biol Chem 276(42):38353–38360
Silva PN et al (2006) Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology. Biochem J 398(1):83–95
Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4(11):a011254
Yang SH, Sharrocks AD, Whitmarsh AJ (2013) MAP kinase signalling cascades and transcriptional regulation. Gene 513(1):1–13
Zeke A et al (2016) JNK signaling: regulation and functions based on complex protein–protein partnerships. Microbiol Mol Biol Rev 80(3):793–835
Krishna M, Narang H (2008) The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65(22):3525–3544
Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol 16(4):343–353
Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80(2):179–185
Plotnikov A et al (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813(9):1619–1633
Hazzalin CA, Mahadevan LC (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 3(1):30–40
Dunn C et al (2002) Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal 14(7):585–593
Liu X et al (2012) Varicella-Zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis. J Virol 86(6):3143–3151
Shi W et al (2014) MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells. Virol J 11:227
Liu X, Cohen JI (2015) Epstein–Barr virus (EBV) tegument protein BGLF2 promotes EBV reactivation through activation of the p38 mitogen-activated protein kinase. J Virol 90(2):1129–1138
Torres AA et al (2016) Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation. J Gen Virol 97(9):2346–2351
Pereira AC et al (2012) A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization. J Virol 86(1):172–184
Tournier C et al (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288(5467):870–874
Alam J et al (1999) Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274(37):26071–26078
Husain M, Moss B (2001) Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles. J Virol 75(16):7528–7542
Joklik WK (1962) The purification fo four strains of poxvirus. Virology 18:9–18
Sambrook J, Fritsch EF, Maniats T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor, Cold Spring Harbor Laboratory
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103(2):239–252
Schreck I et al (2011) c-Jun localizes to the nucleus independent of its phosphorylation by and interaction with JNK and vice versa promotes nuclear accumulation of JNK. Biochem Biophys Res Commun 407(4):735–740
Moss B (2013) Poxvirus DNA replication. Cold Spring Harb Perspect Biol 5(9):a010199
Schwachtgen JL, Campbell CJ, Braddock M (2000) Full promoter sequence of human early growth response factor-1 (Egr-1): demonstration of a fifth functional serum response element. DNA Seq 10(6):429–432
Alto NM, Orth K (2012) Subversion of cell signaling by pathogens. Cold Spring Harb Perspect Biol 4(9):a006114
Soares JA et al (2009) Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol 83(13):6883–6899
Schweneker M et al (2012) The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence. J Virol 86(4):2323–2336
Leppa S et al (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J 17(15):4404–4413
Avey D et al (2015) Phosphoproteomic analysis of KSHV-infected cells reveals roles of ORF45-activated RSK during lytic replication. PLoS Pathog 11(7):e1004993
Zhang W et al (2016) ERK/c-Jun recruits Tet1 to induce Zta expression and Epstein–Barr virus reactivation through DNA demethylation. Sci Rep 6:34543
Santos CR et al (2006) Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling. J Virol 80(15):7667–7675
Oh J, Broyles SS (2005) Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes. J Virol 79(20):12852–12860
Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3(11):859–868
Leite F, Way M (2015) The role of signalling and the cytoskeleton during Vaccinia virus egress. Virus Res 209:87–99
Javelaud D et al (2003) Disruption of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem 278(27):24624–24628
Cowan KJ, Storey KB (2003) Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206(Pt 7):1107–1115
Xie J et al (2005) Kaposi’s sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways. J Virol 79(24):15027–15037
Benn J et al (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70(8):4978–4985
Nijhara R et al (2001) Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol 75(21):10348–10358
Acknowledgements
We thank Dr. Jawed Alam (Alton Ochsner Medical Foundation, New Orleans, Louisiana, USA) who kindly provided us with the c-Jun DNA constructs. We also thank Dr. M. C. Sogayar (Department of Biochemistry, University of São Paulo, São Paulo, Brazil), who kindly provided us with the A31 cell line, and Dr. R. Davis (Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA) for the WT and JNK1/2KO cells. We also thank Dr. B. Moss (NIAID, Bethesda, MD, USA) for kindly providing us with VACV WR and VACV F13L-GFP. We deeply thank Angela S. Lopes, Ilda M. V. Gama (in memorian), Maria A. Souza, João R. dos Santos, and Paula Marinho for their secretarial/technical assistance. F. G. G. L., A. A. T., A. F. P., J. A. P. S. M. and A. C. T. C. P. were recipients of pre-doctoral fellowships from CNPq/CAPES. De Oliveira, L. C. is recipient of a research fellowship from FAPEMIG. C. A. B., E. G. K., G. S. T. and J. S. A are recipients of CNPq research fellowships.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the Fundação para o Desenvolvimento da Ciência do Estado de Minas Gerais (FAPEMIG), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and the Conselho Nacional para o Desenvolvimento Científico e Tecnológico (CNPq)/BRAZIL.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Leite, F.G.G., Torres, A.A., De Oliveira, L.C. et al. c-Jun integrates signals from both MEK/ERK and MKK/JNK pathways upon vaccinia virus infection. Arch Virol 162, 2971–2981 (2017). https://doi.org/10.1007/s00705-017-3446-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-017-3446-6